180 Life Sciences (ATNF) Acquires 82K ETH After $425M Raise
180 Life Sciences Corp. (NASDAQ:ATNF) is a formerly clinical-stage biotechnology company that has strategically transformed its business model…
Syndax (SNDX) Surges 40.5% in 3 Months
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is a clinical and now commercial-stage biopharmaceutical company committed to developing and delivering transformative…
Armata Pharma (ARMP) Skyrockets 103% in One Day
Armata Pharmaceuticals Inc. (NYSE:ARMP) is a clinical-stage biotechnology company focused on pioneering bacteriophage-based therapeutics, a groundbreaking approach to…
Genprex (GNPX) Raises $2.7M to Accelerate FDA Fast Track Trials
Genprex Inc. (NASDAQ:GNPX) is a clinical-stage gene therapy company headquartered in Austin, Texas, focused on developing transformative, potentially…
Hedge Funds Are Quietly Loading Up on Neuphoria (NEUP)
Neuphoria Therapeutics Inc. (NASDAQ:NEUP) is a clinical-stage biotechnology company focused on developing next-generation treatments for neuropsychiatric disorders through…
Genenta Science (GNTA) Surges 91%!!!
Genenta Science S.p.A. (NASDAQ:GNTA) is a clinical-stage biotechnology company headquartered in Milan, Italy, pioneering a breakthrough approach to…
Inhibrx (INBX) Surges After Ozekibart Cuts Cancer Progression Risk by 52%
Inhibrx Inc. (NASDAQ:INBX) is a clinical-stage biopharmaceutical company focused on developing a new generation of therapeutic candidates designed…
Addex Therapeutics (ADXN) is on the Brink of a Breakout
Addex Therapeutics Ltd. (NASDAQ:ADXN) is a clinical-stage biopharmaceutical company based in Geneva, Switzerland, specializing in the discovery and…
Picard Medical (PMED) Plunges 59.77% in One Day
Picard Medical Inc. (NASDAQ:PMED) is an emerging medical technology company focused on transforming the treatment landscape for men’s…
Coya Therapeutics (COYA) Could Be the Next 5X Biotech
Coya Therapeutics Inc. (NASDAQ:COYA) is a clinical-stage biotechnology company pioneering a new class of therapies designed to harness…
Teladoc Health (TDOC) Posts $626.4M in Quarterly Revenue
Teladoc Health Inc. (NYSE:TDOC) is a global pioneer in virtual healthcare and one of the most influential companies…
Sagimet Biosciences (SGMT) Set for 273% Surge After Buy Rating
Sagimet Biosciences Inc. (NASDAQ:SGMT) is a clinical-stage biopharmaceutical company dedicated to developing transformative therapies that target the underlying…
X4 Pharma (XFOR) Targets 44% Annual Growth as Analysts See Upside
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) is a late-stage clinical biopharmaceutical company founded with a mission to develop innovative therapies…
Tenax (TENX) Could Be the Best-Funded Microcap in Biotech
Tenax Therapeutics, Inc. (NASDAQ:TENX) is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies for life-threatening…
Capricor Therapeutics (CAPR) Near All-Time Lows
Capricor Therapeutics (NASDAQ:CAPR) is a biotechnology company founded with a mission to develop transformative cell and exosome-based therapies…
Windtree (WINT) Targets Profitability After Eliminating $8.8M in R&D Costs
Windtree Therapeutics Inc. (NASDAQ:WINT) is a diversified life sciences and emerging environmental services company with a long-established foundation…
Sight Sciences (SGHT) Surges 37% in One Month
Sight Sciences Inc. (NASDAQ:SGHT) is a medical technology company dedicated to transforming the treatment of eye diseases through…
SELLAS (SLS) Surged 40% After Hours on New AML Data
SELLAS Life Sciences Group Inc. (NASDAQ:SLS) is a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies designed…